Long-term Outcomes of Secondary Narcolepsy in Childhood and Adolescence
Overview
Tab Title Description
Study type
ObservationalDescribes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Study IDs
Site IRB
- Rochester, Minnesota: 17-005734
Sponsor Protocol Number: 17-005734
About this study
The purpose of this study is to document the long-term outcomes of secondary (symptomatic) narcolepsy in the pediatric patient population at the Mayo Clinic using chart review and mailed questionnaire.
Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria:
- Mayo Clinic patients with secondary narcolepsy who were between age 5 and 18 years at the time of narcolepsy diagnosis.
- The diagnosis will need to have been established on the basis of nocturnal polysomnogram (PSG) and MSLT.
Exclusion Criteria:
- Idiopathic narcolepsy
- Hypersomnia unrelated to narcolepsy
- Age over 18 at time of diagnosis
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
| Mayo Clinic Location |
Status |
|
Rochester, Minn.
Mayo Clinic principal investigator Suresh Kotagal, M.D. |
Closed for enrollment |
|
More information
Publications
Publications are currently not available